Case report: Area of focus of management of severe pityriasis rubra pilaris by dose optimization of adalimumab biosimilar in combination with acitretin and montelukast

Case report: Area of focus of management of severe pityriasis rubra pilaris by dose optimization of adalimumab biosimilar in combination with acitretin and montelukast

Pityriasis rubra pilaris (PRP) is a rare inflammatory skin disorder characterized by hyperkeratotic follicular papules, orange-red scaling plaques with islands of sparing and palmoplantar keratoderma. While spontaneous resolution occurs in some cases, treatment can be challenging for others. The use...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Kristine Heidemeyer, S. Morteza Seyed Jafari, Lena Farnina, Simon Bossart, Laurence Feldmeyer, Nikhil Yawalkar
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Frontiers Media S.A. 2023-11-01
Ráidu:Frontiers in Medicine
Fáttát:
pityriasis rubra pilaris
adalimumab
biosimilar
dose-optimization
phospholipase A2
montelukast
Liŋkkat:https://www.frontiersin.org/articles/10.3389/fmed.2023.1295777/full

Interneahtta

https://www.frontiersin.org/articles/10.3389/fmed.2023.1295777/full

Geahča maid